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Biological membranes remodel in lipid pore formation, fusion, endocytosis and
other processes. Traditionally, continuum membrane mechanics has been used
to describe the physics of these remodelings. Membrane mechanics is a conser-
vative, equilibrium theory and so cannot, a priori, describe the time course, flows
and dissipations of a real system. Over the past few decades, physical scientists
andmathematicians have developedglobalmulti-physics field equations that de-
scribe the time course of processes for condensedmatter in a thermodynamically
consistent way. We use these equations to describe the membrane during lipid
bilayer membrane remodelings. We analyze the vesicle membrane and its lipid
layers as a bulk continuum variable in a Hamiltonian. The Hamiltonian includes
the surface tension and curvature effects of the classicalHelfrichmodel. The rep-
resentations are, however, more flexible and can readily account for multicom-
ponent systems, inhomogeneities, and changes in topology. Coupling the
Hamiltonian to the motion of the aqueous medium with Rayleigh dissipation
leads to a complicated, self-consistent system of partial differential equations
that is solved numerically. Numerical schemes, designed specifically for this
field theory, provide the position, velocity and forces of the fluid–vesicle system
at each point in space and time. Classical models assume a specific shape for the
vesicle (e.g., a sphere). The assumed shapewill occur in the real world, however,
only if it is a self-consistent solution of the equations. Our calculations yield
values of all key variables and energies over time-the shape is an output. Movies
that precisely illustrate the time evolution of the membrane configuration are
generated. Changes over time are appreciated visually without reference to the
equations–or even to the physics–of the remodeling processes.
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Diastolic Ca2þ leak from the sarcoplasmic reticulum (SR) via the ryanodine re-
ceptor (RyR2) contributes to arrhythmias. Protein kinase A (PKA) and Ca2þ/
Calmodulin- dependent protein kinase II (CaMKII) have been involved in SR
Ca2þ leak by altering RyR2 gating. Under these conditions, JTV519 (K201),
a benzothiazepine derivate, has been shown to stabilize the modified RyR2
and reduce diastolic SR Ca2þ leak. We tested, whether JTV519 reduces SR
Ca2þ leak induced by Naþ- and Ca2þ overload (induced by 100 mM ouabain),
i.e. independent of CaMKII signaling. Methods: [Ca2þ]i was measured
(Fluo4-AM, confocal) in paced murine cardiomyocytes 5JTV519 (1 mM,
>1h preincubation). [Ca2þ]-transients, diastolic SR Ca2þ leak (Ca2þ spark
(SparkF, in s1*pL1) and Ca2þ wave frequency) and SR [Ca2þ] (caffein)
were measured5ouabain (OUAB) and KN93 (CaMKII-inhibitor, 1 mM). Phos-
phorylation of RyR2 (pSer2814, CaMKII site) was quantified by Western blot.
Results: With OUAB, total cellular [Ca2þ] increased from 3.350.3 to 4.350.3
(F/F0, mean5SE), SparkF increased from 31520 to 85530 (both p&lt;0.05).
Ouabain did not increase pSer2814, and KN93 had no effect on elevated
SparkF with ouabain (89524), indicating no contribution of CaMKII to in-
creased SR Ca2þ leak. JTV519 decreased SparkF (2554), and Ca2þ waves,
but also attenuated the increase in SR [Ca2þ] in OUAB (F/F0: 5.250.3 with
JTVþOuab vs. 7.750.6 OUAB, p&lt;0.05). However, matching cells for equal
SR [Ca2þ] revealed an SR [Ca2þ] - independent effect of JTV519 on SparkF. In
contrast, propagation speed of Ca2þ waves and the ratio between [Ca2þ] tran-
sient amplitude and SR [Ca2þ] were unchanged.
Conclusion: In conditions not related to CaMKII-mediated alterations of RyR2
gating, JTV519 reduces spontaneous SR Ca2þ release, but does not influence
propagated Ca2þ release or the fraction of SR Ca2þ released with each beat.
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AICAR, an AMP-activated protein kinase (AMPK) agonist, increases the effi-
ciency of murine oxygen metabolism, dramatically increasing exercise endur-ance (Cell 134:405, 2008). AICAR also prevents heat-induced death in
malignant hyperthermia(MH)-susceptible transgenic mice (RyR1-Y522S/WT)
without changes in AMPK phosphorylation, and suppresses intracellular Ca2þ
levels by an unknown mechanism (Lanner JT et al, 2010 Biophysical Society
Meeting Abstracts). Store Operated Ca2þ Entry (SOCE) restores Ca2þ to de-
pleted sarcorendoplasmic reticulum fromextracellular stores. Since azumolene,
a drug which inhibits MH, suppresses the RyR1-dependent rise in intracellular
Ca2þ by inhibiting SOCE rather than Ca2þ release, we sought to determine
whether AICAR affects Ca2þ homeostasis similarly. We compared CHO cells
stably transfected with RyR1 (C1148) with wild type (CHO-wt). Single cell
Ca2þ imaging was performed in Fura-2 AM-loaded cells. Changes in intracellu-
lar Ca2þwere followed as changes in the ratio l340/380, and SOCEmeasured by
Mn2þ-quenching of Fura-2 fluorescence (l360). In C1148 cells, AICAR (1 mM,
overnight) suppresses Ca2þ-release by theRyR1 agonists, caffeine and4-Chloro-
m-Cresol (4-CMC). Western blot and immunofluorescence analysis do not
show any change in the expression of RyR1 or STIM1. The elevated SOCE in
C1148 cells is largely inhibited by AICAR (1 mM) and virtually completely by
the specific SOCE inhibitor BTP2 (1mM). SOCE stimulated by the SR Ca2þ-
pump inhibitor, CPA (10 mM), was inhibited by BTP2, but not by AICAR. The
ER Ca2þ store in C1148 cells is much lower than that of CHO-wt, irrespective
of AICAR treatment status. AICAR has no significant effect on [3H]ryanodine-
binding to skeletal muscle SR vesicles, nor does it have any effect on
sarcorendoplasmic reticulumCa2þ-ATPase activity.We conclude that AICAR,
like azumolene, partially inhibits the RyR1-dependent SOCE, but not Ca2þ-
ATPase-dependent SOCE.These data also suggest thatAICARmaybe therapeu-
tic in treating MH.
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Mutations in the cardiac ryanodine receptor (RyR2) have been implicated in
Catecholaminergic Polymorphic Ventricular Tachicardia 1 (CPVT1), an ar-
rhythmogenic syndrome triggered by emotional or physical stress in otherwise
healthy individuals. At the cellular level, the adrenergic surge during stress pre-
sumably induces diastolic SR Ca2þ release, generating a favorable substrate
for arrhythmias by the mechanism of delayed afterdepolarization (DAD). In-
creased sensitivity to luminal [Ca2þ], unzipping of domain-domain interac-
tions, and de-regulation by accessory proteins have been reported to
contribute to RyR2 dysfunction in CPVT1. We generated a knock-in mouse
model of CPVT1 (RyR2-V2475F) and characterized its mechanisms of arrhyth-
mia. Expression of RyR2-V2475F in HEK293 cells induces a unique pheno-
type, namely, increased activity at diastolic [Ca2þ] (pCa 7), which is not
seen in other CPVT1 mutations. Mice homozygous for the V2475F mutation
have not been detected in >500 mice, suggesting that the mutation causes cat-
astrophic RyR2 dysfunction and embryonic lethality. Heterozygous mice, on
the other hand, display increased propensity for premature ventricular com-
plexes, bidirectional ventricular tachycardia and other forms of tachyarryth-
mias when injected a cocktail of norepinephrine and caffeine that is mostly
innocuous in wild-type mice. Heterozygous Langendorff-perfused hearts sub-
jected to adrenergic stimulation and tachypacing are also arrhythmogenic, in-
dicating that the arrhythmias arise from mechanisms intrinsic to the heart
and not necessarily from systemic factors. Despite this severe phenotype, ven-
tricular cardiomyocytes isolated from RyR2-V2475F mice display only mild
differences in the amplitude and kinetics of intracellular Ca2þ transients
when compared to wild-type myocytes, regardless of stimulation frequency
and b-adrenergic stimulation. Thus, cellular Ca2þ mishandling in ventricular
myocytes of the RyR2-V2475F mice, although significant, does not appear suf-
ficient to support the severe phenotype observed in whole hearts and intact
mice. We are therefore investigating other mechanisms that may explain the
arrhythmogenicity of heterozygous mice.
1029-Plat
FRET-Based Mapping of Three Structural Domains within the Full-
Length Ryanodine Receptor Type 1
James D. Fessenden.
Boston Biomedical Research Institute, Watertown, MA, USA.
The type 1 ryanodine receptor (RyR1) mediates excitation contraction cou-
pling in skeletal muscle by releasing intracellular calcium in response to cell
depolarization. Understanding the structure and conformational dynamics of
RyR1 is challenging due to its size (homotetrameric subunit Mr~560 kDa)
and its association with numerous regulatory proteins. However, recent X-
ray crystallographic studies indicate that a fragment comprised of the first
200 amino acids of RyR1 folds into a compact b-trefoil domain. Based on
structural homology with the inositol trisphosphate receptor, the next 400
